Scl binds to primed enhancers in mesoderm to regulate hematopoietic and cardiac fate divergence. (7th January 2015) - Org, Tõnis
Abstract Previous work had revealed that Scl promotes hemogenic competence while repressing cardiac fate. Comprehensive genome‐scale data presented here establish Scl‐mediated 'enhancer decommissioning' as underlying molecular mechanism.